STAT3 and cancer: Studies have shown that HECT domain and RCC1-like domain 2 (HERC2) enhance cancer stemness and PD-L1-mediated immune escape of HCC cells, which is associated with activation of the STAT3 pathway during the inflammation-cancer transformation.